Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Fundamental & Clinical Pharmacology|March 31, 2015
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practiceMarie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Fabienne Thomas, et al.
The Pharmacogenomics Journal|November 2, 2019
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysisMasanobu Takeuchi, Tohru Kobayashi, Tina Biss, et al.
Bulletin Du Cancer|June 30, 2019
[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists]Marie-Anne Loriot, Fadil Masskouri, Paolo Carni, et al.
Bulletin Du Cancer|March 1, 2018
[Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks]Marie-Anne Loriot, Joseph Ciccolini, Fabienne Thomas, et al.
Human Molecular Genetics|November 19, 2010
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European populationMohamad Saad, Suzanne Lesage, Aude Saint-Pierre, et al.
British Journal of Cancer|January 15, 2024
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysisGwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, et al.
Annals of Neurology|March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAlexis Elbaz, Owen A Ross, John P A Ioannidis, et al.
Neurobiology of Aging|August 22, 2013
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsMichael G Heckman, Alexis Elbaz, Alexandra I Soto-Ortolaza, et al.
Clinical Pharmacology and Therapeutics|December 4, 2018
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 IndividualsElisa Danese, Sara Raimondi, Martina Montagnana, et al.
Pageof 9